Last update 01 Nov 2024
iLab Co., Ltd

iLab Co., Ltd

Holding Company|
2017|
Gyeonggi-do, South Korea
|
www.ilab.co.kr

Overview

Tags

Neoplasms
Immune System Diseases
Skin and Musculoskeletal Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms3
Immune System Diseases1
Top 5 Drug TypeCount
Small molecule drug5
Top 5 TargetCount
IL-6(Interleukin-6)1
CSF-2R x PDL11
CSF-1R(Colony stimulating factor 1 receptor)1
TNF-α(Tumor necrosis factor α)1

Related

5
Drugs associated with iLab Co., Ltd
IA-14069
Target
TNF-α
Mechanism
TNF-α inhibitors
Active Org.
iLab Co., LtdiLab Co., Ltd
Originator Org.
iLab Co., LtdiLab Co., Ltd
Active Indication
Rheumatoid Arthritis
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
Anti-inflammatory project (ILAb)
Target
IL-6
Mechanism
IL-6 inhibitors
Active Org.
iLab Co., LtdiLab Co., Ltd
Originator Org.
iLab Co., LtdiLab Co., Ltd
Active Indication
Inflammation
Inactive Indication-
Drug Highest PhaseDiscovery
First Approval Ctry. / Loc.-
First Approval Date-
CSF1R program (iLab)
Target
CSF-1R
Mechanism
CSF-1R modulators
Active Org.
iLab Co., LtdiLab Co., Ltd
Originator Org.
iLab Co., LtdiLab Co., Ltd
Active Indication
Neoplasms
Inactive Indication-
Drug Highest PhaseDiscovery
First Approval Ctry. / Loc.-
First Approval Date-
2
Clinical Trials associated with iLab Co., Ltd
NCT05533372 / RecruitingPhase 1
Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IA-14069 in Healthy Subjects, With an Extension to Explore Any Drug-Drug Interaction Potential With Methotrexate (Part 1), and in Patients With Rheumatoid Arthritis, With Preliminary Assessment of Efficacy in Patients (Part 2)
NCT05317741 / CompletedPhase 1
A Phase 1, First-in-human, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Food Effect, and Pharmacodynamics Following a Single Oral Dose of IA-14069 in Healthy Male Subjects
100 Clinical Results associated with iLab Co., Ltd
Login to view more data
0 Patents (Medical) associated with iLab Co., Ltd
Login to view more data
100 Deals associated with iLab Co., Ltd
Login to view more data
100 Translational Medicine associated with iLab Co., Ltd
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
4
1
Phase 1 Clinical
Login to view more data

Current Projects

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free